SH

Sharad Hemrajbhai Gangani

Active Director Designated Partner DIN 08448897
DIN 08448897 First appointment May 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharad Hemrajbhai Gangani

Data last updated:

Sharad Hemrajbhai Gangani is a Designated Partner at Illwane Pharmaceuticals Llp (since 2019). The company operates in Business Services.

DIN 08448897
Primary Designation Designated Partner
Industry Business Services
First Appointment 10 May 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 May 20192019Active

Board colleagues of Sharad Hemrajbhai Gangani

NameDINCompanyDesignation
Mamta Sharad Gangani10323037Illwane Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Illwane Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sharad Hemrajbhai Gangani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharad Hemrajbhai Gangani

Sharad Hemrajbhai Gangani currently holds 1 directorship: Illwane Pharmaceuticals Llp (Designated Partner, since 10 May 2019).

Sharad Hemrajbhai Gangani was first appointed on 10 May 2019 as Designated Partner at Illwane Pharmaceuticals Llp.

The current boards of Sharad Hemrajbhai Gangani's companies include Mamta Sharad Gangani (Illwane Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available